Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:676-677
doi: 10.1161/01.ATV.0000201930.10103.be
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Röcken, C.
Right arrow Articles by Bürger, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Röcken, C.
Right arrow Articles by Bürger, T.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:676.)
© 2006 American Heart Association, Inc.


Letters to the Editor

Prevalence and Pathology of Amyloid in Atherosclerotic Arteries

Christoph Röcken; Jörg Tautenhahn; Frank Bühling; Daniela Sachwitz; Steffi Vöckler; Andreas Goette; Thomas Bürger

From the Departments of Pathology (C.R., D.S., S.V.), General Surgery (J.T.), and Immunology (F.B.), Otto-von-Guericke-University Magdeburg, Germany; the Department of Clinical and Laboratory Medicine (F.B.), Cottbus, Germany; the Division of Cardiology (A.G.), of the Otto-von-Guericke-University Magdeburg, Germany; and the Diakonissen Krankenhaus (T.B.), Kassel, Germany.

Correspondence to Prof Dr med Christoph Röcken, Department of Pathology, Charité University Hospital, Schumannstr. 20/21, D-10117 Berlin, Germany. E-mail rockenc@gmx.de


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

Apolipoprotein AI (AApoAI)–associated amyloidosis is characterized by the deposition of apolipoprotein AI (apoAI) and occurs as a hereditary and a nonhereditary form. Hereditary AApoAI amyloidosis is a systemic disease leading to the deposition of amyloid in various organs and tissues and is caused by germline mutations in the APOA1 gene. Nonhereditary AApoAI amyloid is far more prevalent and characterized by deposits of nonvariant protein in atherosclerotic arteries.1–3 Despite being linked to the most common cause of morbidity and mortality in Western societies, nonhereditary AApoAI amyloid has achieved only little attention.1–4 It shares several striking similarities with secondary or reactive AA amyloidosis. Nonhereditary AApoAI amyloid occurs in the background of a local chronic inflammatory reaction, it originates from an apolipoprotein that largely associates with high-density lipoproteins (HDLs), and apoAI-containing HDL is endocytosed and retroendocytosed by macrophages, which, in themselves, are able to form amyloid in vitro. Finally, AApoAI amyloidosis is characterized by the deposition of proteolytic fragments of the precursor protein, leading us to speculate that proteolysis is involved in the pathogenesis of AApoAI amyloid.1,3 The aim of this study was to gain further insights into the pathology of nonhereditary AApoAI amyloid.

See cover

The prevalence and spatial distribution of amyloid, macrophages, cathepsin B (CathB), cathepsin K (CathK), cathepsin L (CathL), and carboxy methyl lysine (CML) was studied using carotid artery specimens obtained from a consecutive series of all 225 patients undergoing carotid endarterectomy with polyester patch angioplasty (Table I, available online at http://atvb.ahajournals.org) during the period from . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
RadiologyHome page
N. Altaf, P. S. Morgan, A. Moody, S. T. MacSweeney, J. R. Gladman, and D. P. Auer
Brain White Matter Hyperintensities Are Associated with Carotid Intraplaque Hemorrhage
Radiology, July 1, 2008; 248(1): 202 - 209.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. Herczenik and M. F. B. G. Gebbink
Molecular and cellular aspects of protein misfolding and disease
FASEB J, July 1, 2008; 22(7): 2115 - 2133.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Herrmann, S. M. Soares, L. O. Lerman, and A. Lerman
Potential Role of the Ubiquitin-Proteasome System in Atherosclerosis: Aspects of a Protein Quality Disease
J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2003 - 2010.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Gunzburg, M. A. Perugini, and G. J. Howlett
Structural Basis for the Recognition and Cross-linking of Amyloid Fibrils by Human Apolipoprotein E
J. Biol. Chem., December 7, 2007; 282(49): 35831 - 35841.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. R. Stewart, A. Haw III, R. Lopez, T. O. McDonald, J. M. Callaghan, M. J. McConville, K. J. Moore, G. J. Howlett, and K. D. O'Brien
Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications
J. Lipid Res., October 1, 2007; 48(10): 2162 - 2171.
[Abstract] [Full Text] [PDF]